These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
102 related articles for article (PubMed ID: 8466723)
1. Calcium antagonists and atherosclerosis. The Multicenter Isradipine/Diuretic Atherosclerosis Study. Furberg CD; Borhani NO; Byington RP; Gibbons ME; Sowers JR Am J Hypertens; 1993 Mar; 6(3 Pt 2):24S-29S. PubMed ID: 8466723 [TBL] [Abstract][Full Text] [Related]
2. MIDAS: rationale, design and descriptive data of trial patients. The MIDAS Research Group. Borhani NO Blood Press Suppl; 1994; 1():29-35. PubMed ID: 8205295 [TBL] [Abstract][Full Text] [Related]
3. Final outcome results of the Multicenter Isradipine Diuretic Atherosclerosis Study (MIDAS). A randomized controlled trial. Borhani NO; Mercuri M; Borhani PA; Buckalew VM; Canossa-Terris M; Carr AA; Kappagoda T; Rocco MV; Schnaper HW; Sowers JR; Bond MG JAMA; 1996 Sep; 276(10):785-91. PubMed ID: 8769587 [TBL] [Abstract][Full Text] [Related]
4. MIDAS, the Multicenter Isradipine/Diuretic Atherosclerosis Study. Design features and baseline data. Applegate WB; Byington RP Am J Hypertens; 1991 Feb; 4(2 Pt 2):114S-117S. PubMed ID: 1827000 [TBL] [Abstract][Full Text] [Related]
5. The antiatherosclerotic effect of calcium antagonists in man--what did MIDAS actually show? Multicenter Isradipine Diuretic Atherosclerosis Study. Hansson L; Zanchetti A Blood Press; 1995 May; 4(3):133-6. PubMed ID: 7670645 [TBL] [Abstract][Full Text] [Related]
6. The Multicenter Isradipine/Diuretic Atherosclerosis Study: a study of the antiatherogenic properties of isradipine in hypertensive patients. MIDAS Research Group. Borhani NO; Bond MG; Sowers JR; Canossa-Terris M; Buckalew V; Gibbons ME; Worthy AJ J Cardiovasc Pharmacol; 1991; 18 Suppl 3():S15-9. PubMed ID: 1720479 [TBL] [Abstract][Full Text] [Related]
7. Multicenter isradipine diuretic atherosclerosis study (MIDAS). Design features. The Midas Research Group. Furberg CD; Byington RP; Borhani NA Am J Med; 1989 Apr; 86(4A):37-9. PubMed ID: 2523653 [TBL] [Abstract][Full Text] [Related]
8. MIDAS: hypertension and atherosclerosis. A trial of the effects of antihypertensive drug treatment on atherosclerosis. MIDAS Research Group. Borhani NO; Miller ST; Brugger SB; Schnaper HW; Craven TE; Bond MG; Khoury S; Flack J J Cardiovasc Pharmacol; 1992; 19 Suppl 3():S16-20. PubMed ID: 1376828 [TBL] [Abstract][Full Text] [Related]
9. A comparison of antihypertensive drug effects on the progression of extracranial carotid atherosclerosis. The Multicenter Isradipine Diuretic Atherosclerosis Study (MIDAS). Grimm RH; Flack JM; Byington R; Bond G; Brugger S Drugs; 1990; 40 Suppl 2():38-43. PubMed ID: 2150640 [TBL] [Abstract][Full Text] [Related]
10. Risk factors associated with alterations in carotid intima-media thickness in hypertension: baseline data from the European Lacidipine Study on Atherosclerosis. Zanchetti A; Bond MG; Hennig M; Neiss A; Mancia G; Dal Palù C; Hansson L; Magnani B; Rahn KH; Reid J; Rodicio J; Safar M; Eckes L; Ravinetto R J Hypertens; 1998 Jul; 16(7):949-61. PubMed ID: 9794735 [TBL] [Abstract][Full Text] [Related]
11. Pravastatin, lipids, and atherosclerosis in the carotid arteries: design features of a clinical trial with carotid atherosclerosis outcome. Crouse JR; Byington RP; Bond MG; Espeland MA; Sprinkle JW; McGovern M; Furberg CD Control Clin Trials; 1992 Dec; 13(6):495-506. PubMed ID: 1334821 [TBL] [Abstract][Full Text] [Related]
12. Multicenter study with isradipine and diuretics against atherosclerosis. US MIDAS Research Group. Borhani NO; Brugger SB; Byington RP J Cardiovasc Pharmacol; 1990; 15 Suppl 1():S23-9. PubMed ID: 1695298 [TBL] [Abstract][Full Text] [Related]
13. The Multicenter Isradipine Diuretic Atherosclerosis Study (MIDAS). Kaufman JL JAMA; 1997 Jan 22-29; 277(4):297; author reply 297-8. PubMed ID: 9002486 [No Abstract] [Full Text] [Related]
14. How to study the role of hypertension in atherosclerosis. Lessons from MIDAS. Multicentre Isradipine Diuretic Atherosclerosis Study. Hansson L Blood Press Suppl; 1996; 4():16-9. PubMed ID: 8973777 [TBL] [Abstract][Full Text] [Related]
16. Isradipine in prediabetic hypertensive subjects. Byington RP; Furberg CD; Craven TE; Pahor M; Sowers JR Diabetes Care; 1998 Dec; 21(12):2103-10. PubMed ID: 9839101 [TBL] [Abstract][Full Text] [Related]
17. Detection and monitoring of asymptomatic atherosclerosis in clinical trials. Bond MG; Wilmoth SK; Enevold GL; Strickland HL Am J Med; 1989 Apr; 86(4A):33-6. PubMed ID: 2523652 [TBL] [Abstract][Full Text] [Related]
18. Associations of risk factors with segment-specific intimal-medial thickness of the extracranial carotid artery. Espeland MA; Tang R; Terry JG; Davis DH; Mercuri M; Crouse JR Stroke; 1999 May; 30(5):1047-55. PubMed ID: 10229743 [TBL] [Abstract][Full Text] [Related]
19. Preliminary clinical experience with calcium antagonists in atherosclerosis. Verapamil in Hypertension Atherosclerosis Study Investigators. Magnani B; Dal Palù C; Zanchetti A Drugs; 1992; 44 Suppl 1():128-33. PubMed ID: 1283576 [TBL] [Abstract][Full Text] [Related]
20. Spatial distribution of carotid intimal-medial thickness as measured by B-mode ultrasonography. Espeland MA; Hoen H; Byington R; Howard G; Riley WA; Furberg CD Stroke; 1994 Sep; 25(9):1812-9. PubMed ID: 8073462 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]